Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Urigen Pharmaceuticals, Inc. (URGP)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-14 | Jun-30-13 | Jun-30-10 | Jun-30-09 | Jun-30-08 | Jun-30-07 | Jun-30-06 | Jun-30-05 |
| | S-1 | S-1 | 10-K | 10-K | 10-K | 10-K | 10-K/A | 10-K/A |
| Revenues | | | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | | | 2966.8% | 824.9% | 100.0% | 100.0% | 738.4% | 188.7% |
| Gross profit | | | -2866.8% | -724.9% | 0.0% | 0.0% | -638.4% | -88.7% |
| Sales and marketing | | | | 39.5% | 38.6% | 39.0% | | |
| General and administrative | | | 2966.8% | 785.4% | 403.6% | 287.0% | 738.4% | 188.7% |
| Depreciation | | | 3.7% | 2.1% | 0.9% | 0.3% | 4.8% | 2.2% |
| EBITA | | | -3037.4% | -917.5% | -540.1% | -424.1% | -2143.2% | -518.0% |
| Amortization of intangibles | | | 29.3% | 7.4% | 2.1% | 1.9% | | |
| EBIT | | | -3066.8% | -924.9% | -542.2% | -426.0% | -2143.2% | -518.0% |
| Pre-tax income | | | -2684.0% | -1156.4% | -707.9% | -429.0% | -2109.6% | -509.1% |
| Income taxes | | | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | | | -2684.0% | -1156.4% | -707.9% | -429.0% | -2109.6% | -509.1% |
|